AnaptysBio’s (ANAB) Outperform Rating Reiterated at Wedbush
Wedbush reaffirmed their outperform rating on shares of AnaptysBio (NASDAQ:ANAB – Free Report) in a research report report published on Thursday morning,Benzinga reports. They currently have a $40.00 price objective on the biotechnology company’s stock. Several other analysts have also recently commented on ANAB. Wolfe Research assumed coverage on shares of AnaptysBio in a research […]
Wedbush reaffirmed their outperform rating on shares of AnaptysBio (NASDAQ:ANAB – Free Report) in a research report report published on Thursday morning,Benzinga reports. They currently have a $40.00 price objective on the biotechnology company’s stock. Several other analysts have also recently commented on ANAB. Wolfe Research assumed coverage on shares of AnaptysBio in a research […]
